Cure My Disease

Don't miss your cure!

 Log in / Sign up

Your phone might know your pain better than you do

NCT ID NCT06283199

Knowledge-focused Sponsor: Ente Ospedaliero Cantonale, Bellinzona Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 11, 2026 · Last updated Sep 11, 2026

Summary

Researchers are testing whether a smartphone app that asks about pain and function twice a day gives a more accurate picture of musculoskeletal pain than asking patients to remember their symptoms later. About 1,500 adults with musculoskeletal pain will use the app for two months and also report their pain retrospectively at follow-up visits. The study compares the two methods to see if real-time tracking differs from recall-based assessments.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
a smartphone app for ecological momentary assessment of pain and function
What this could lead to
If the app captures pain more accurately than memory, doctors could use real-time tracking to better understand and treat musculoskeletal pain.
What could go wrong
The study may show that app-based tracking is no better than recall, or that patients find it too burdensome to use consistently. Results may not apply to people without smartphones or with different pain conditions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 1,500 people

The number the study aims to enrol. It can still change while the study runs.

Started

Apr 2021

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

patients with musculoskeletal chronic pain with a clinical and imaging diagnosis of an orthopaedic disease such as knee osteoarthritis, hip osteoarthritis, shoulder osteoarthritis, ankle osteoarthritis, rizoathrosis, meniscectomy treatment, rotator cuff tendinopathy, low-back pain, Achille tendinopathy, patellar tendinopathy,and tennis elbow.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Symptomatic patients * Patients able to give informed consent and to follow the protocol of the study (i.e. able to use a smartphone) * Patients \>18 years * BMI \<35 and \>18.5 * Patients with a smartphone with Android or iOS as operative systems Exclusion Criteria: * Patients unable to follow the protocol of the study (i.e. unable to use a smartphone, not owning a smartphone or unwilling to download or use the application) * Patients with a diagnosis of a musculoskeletal injury but without symptoms * Patients without a radiological examination confirming the diagnosis of musculoskeletal disease * Patients with planned surgery in the following 60 days * Pregnant or lactating woman * Patients with other diseases causing pain in the involved joint (e.g. rheumatoid arthritis or other rheumatologic diseases). * Surgical treatment in the last year and intra-articular injection in the last 6 months

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Musculoskeletal pain are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Musculoskeletal Pain

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Musculoskeletal pain

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    2 sites in 2 countries. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • EOC - Orthopaedics and Traumatology Service

    RECRUITING

    Lugano, 6900, Switzerland

  • IRCCS Istituto Ortopedico Rizzoli

    RECRUITING

    Bologna, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.